These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 7668036)
1. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Mark A; Björkstén B; Granström M Vaccine; 1995 May; 13(7):669-73. PubMed ID: 7668036 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin E and G antibodies two years after a booster dose of an aluminium-adsorbed or a fluid DT vaccine in relation to atopy. Mark A; Björkstén B; Granström M Pediatr Allergy Immunol; 1997 May; 8(2):83-7. PubMed ID: 9617777 [TBL] [Abstract][Full Text] [Related]
3. Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III. Aggerbeck H; Wantzin J; Heron I Vaccine; 1996 Sep; 14(13):1265-72. PubMed ID: 8961516 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age. Gajdos V; Soubeyrand B; Vidor E; Richard P; Boyer J; Sadorge C; Fiquet A Hum Vaccin; 2011 May; 7(5):549-56. PubMed ID: 21441781 [TBL] [Abstract][Full Text] [Related]
5. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant. Someya S; Mizuhara H; Murata R; Kurokawa M Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558 [TBL] [Abstract][Full Text] [Related]
6. Pediatric diphtheria and tetanus toxoids-adsorbed vaccine: immune response to the first booster following the diphtheria and tetanus toxoids vaccine primary series. Pichichero ME; Barkin RM; Samuelson JS Pediatr Infect Dis; 1986; 5(4):428-30. PubMed ID: 3487779 [TBL] [Abstract][Full Text] [Related]
7. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid. Trollfors B; Taranger J; Lagergård T; Sundh V Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717 [TBL] [Abstract][Full Text] [Related]
8. Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II. Aggerbeck H; Fenger C; Heron I Vaccine; 1995 Oct; 13(14):1366-74. PubMed ID: 8585295 [TBL] [Abstract][Full Text] [Related]
9. The role of aluminium for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine. Mark A; Granström M Acta Paediatr; 1994 Feb; 83(2):159-63. PubMed ID: 8193494 [TBL] [Abstract][Full Text] [Related]
10. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres. Gupta RK; Griffin P; Rivera R; Siber GR Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents. Mark A; Carlsson RM; Granström M Vaccine; 1999 Apr; 17(15-16):2067-72. PubMed ID: 10217608 [TBL] [Abstract][Full Text] [Related]
12. Intranasal booster vaccination against diphtheria and tetanus in man. Aggerbeck H; Gizurarson S; Wantzin J; Heron I Vaccine; 1997 Feb; 15(3):307-16. PubMed ID: 9139491 [TBL] [Abstract][Full Text] [Related]
13. [A comparative evaluation of the immunological efficacy of ADPT vaccine and ADT-M anatoxin in the immunization of children against diphtheria and tetanus]. Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Panina GM Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):52-5. PubMed ID: 1950266 [TBL] [Abstract][Full Text] [Related]
14. Capture EIA for determination of IgE to diphtheria and tetanus toxins in comparison to RIA. Wahren E; Bengtsson C; Björkstén B; Mark A; Granström M Vaccine; 1998; 16(9-10):873-6. PubMed ID: 9682330 [TBL] [Abstract][Full Text] [Related]
15. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526 [TBL] [Abstract][Full Text] [Related]
16. [The immunological basis of the administration of DTP-polio vaccine]. Cohen H Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905 [TBL] [Abstract][Full Text] [Related]
17. Oral immunization against diphtheria and tetanus infections by fluid diphtheria and tetanus toxoids. Mirchamsy H; Hamedi M; Fateh G; Sassani A Vaccine; 1994 Oct; 12(13):1167-72. PubMed ID: 7530887 [TBL] [Abstract][Full Text] [Related]
18. [The vaccination of children with allergic diseases with reduced doses of adsorbed DT-m anatoxin]. Kostinov MP; Balabolkin II; Maksimova NM; Gervazieva VB; Egor'kov NA; Ovsiannikova IG; Lobanova AN Pediatriia; 1991; (8):26-33. PubMed ID: 1762853 [TBL] [Abstract][Full Text] [Related]
19. [Use of adsorbed diphtheria-tetanus (DT) toxoid containing different doses of antigens in booster immunizations of children]. Egor'kov NA; Moksimova NM; Platonova TV; Chebotareva SV; Lobanova AN Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):47-52. PubMed ID: 2800793 [TBL] [Abstract][Full Text] [Related]
20. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]